Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Revelation Biosciences In...

    NASDAQ: REVB · Real-Time Price · USD
    0.81
    -0.03 (-3.46%)
    At close: Jun 26, 2025, 3:59 PM
    0.83
    3.11%
    Pre-market: Jun 27, 2025, 05:50 AM EDT

    Revelation Biosciences Statistics

    Share Statistics

    Revelation Biosciences has 2.03M shares outstanding. The number of shares has increased by 779.93% in one year.

    Shares Outstanding

    n/a
    		 2.03M

    Shares Change (YoY)

    n/a
    		 779.93%

    Shares Change (QoQ)

    n/a
    		 71.95%

    Owned by Institutions (%)

    n/a
    		 0.3%

    Shares Floating

    n/a
    		 2.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 140,509

    FTD / Avg. Volume

    n/a
    		 13.54%

    Short Selling Information

    The latest short interest is 137.88K, so 14.31% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 137.88K

    Short % of Shares Out

    n/a
    		 14.31%

    Short % of Float

    n/a
    		 15.02%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.17 and the forward PE ratio is -0.43. Revelation Biosciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.17

    Forward PE

    n/a
    		 -0.43

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -0.14

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Revelation Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 3.43

    Quick Ratio

    n/a
    		 3.43

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,879,875

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -97.28% in the last 52 weeks. The beta is -0.09, so Revelation Biosciences's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.09

    52-Week Price Change

    n/a
    		 -97.28%

    50-Day Moving Average

    n/a
    		 2.07

    200-Day Moving Average

    n/a
    		 6.71

    Relative Strength Index (RSI)

    n/a
    		 26.55

    Average Volume (20 Days)

    n/a
    		 1,037,891

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -7.97M

    Net Income

    n/a
    		 -15.04M

    EBITDA

    n/a
    		 -7.95M

    EBIT

    n/a
    		 -7.97M

    Earnings Per Share (EPS)

    n/a
    		 -9.44
    Full Income Statement

    Balance Sheet

    The company has 6.5M in cash and 0 in debt, giving a net cash position of 6.5M.

    Cash & Cash Equivalents

    n/a
    		 6.5M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -40.51B

    Total Assets

    n/a
    		 3.97M

    Working Capital

    n/a
    		 2.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -18.32M and capital expenditures -19.17K, giving a free cash flow of -18.34M.

    Operating Cash Flow

    n/a
    		 -18.32M

    Capital Expenditures

    n/a
    		 -19.17K

    Free Cash Flow

    n/a
    		 -18.34M

    FCF Per Share

    n/a
    		 -52.93
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    REVB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for REVB.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:16.

    Last Split Date

    n/a
    		 Jan 28, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:16

    Scores

    Altman Z-Score

    n/a
    		 -19.95

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist